Evidence map›Paper›PMID 24034702›Full record

ArticleBMC genomics2013

Efficient disruption of Zebrafish genes using a Gal4-containing gene trap.

Jorune Balciuniene, Danielle Nagelberg, Kathleen T Walsh, Diana Camerota, Daphné Georlette, Frédéric Biemar, Gianfranco Bellipanni, Darius Balciunas

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A novelFrontiers in cell and developmental biology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Development of brain ventricular system.Cellular and molecular life sciences : CMLS · 2018
    Review
  15. Article
  16. Article
  17. Etv2 and fli1b function together as key regulators of vasculogenesis and angiogenesis.Arteriosclerosis, thrombosis, and vascular biology · 2015
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jorune BalciunieneDepartment of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA. darius@temple.edu.
Danielle Nagelberg
Kathleen T Walsh
Diana Camerota
Daphné Georlette
Frédéric Biemar
Gianfranco Bellipanni
Darius Balciunas
Temple University · US

Funding

Transposon-based Platform for Insertional Mutagenesis and Genome EngineeringR01HD061749 · NICHD · TEMPLE UNIV OF THE COMMONWEALTH · PI BALCIUNAS, DARIUS · 2010 to 2014
$1.5M
NICHD NIH HHS R01 HD061749NICHD NIH HHS R01-HD061749
6 · The paper itself

Abstract

backgroundExternal development and optical transparency of embryos make zebrafish exceptionally suitable for in vivo insertional mutagenesis using fluorescent proteins to visualize expression patterns of mutated genes. Recently developed Gene Breaking Transposon (GBT) vectors greatly improve the fidelity and mutagenicity of transposon-based gene trap vectors.

resultsWe constructed and tested a bipartite GBT vector with Gal4-VP16 as the primary gene trap reporter. Our vector also contains a UAS:eGFP cassette for direct detection of gene trap events by fluorescence. To confirm gene trap events, we generated a UAS:mRFP tester line. We screened 270 potential founders and established 41 gene trap lines. Three of our gene trap alleles display homozygous lethal phenotypes ranging from embryonic to late larval: nsf( tpl6), atp1a3a(tpl10) and flr(tpl19). Our gene trap cassette is flanked by direct loxP sites, which enabled us to successfully revert nsf( tpl6), atp1a3a(tpl10) and flr(tpl19) gene trap alleles by injection of Cre mRNA. The UAS:eGFP cassette is flanked by direct FRT sites. It can be readily removed by injection of Flp mRNA for use of our gene trap alleles with other tissue-specific GFP-marked lines. The Gal4-VP16 component of our vector provides two important advantages over other GBT vectors. The first is increased sensitivity, which enabled us to detect previously unnoticed expression of nsf in the pancreas. The second advantage is that all our gene trap lines, including integrations into non-essential genes, can be used as highly specific Gal4 drivers for expression of other transgenes under the control of Gal4 UAS.

conclusionsThe Gal4-containing bipartite Gene Breaking Transposon vector presented here retains high specificity for integrations into genes, high mutagenicity and revertibility by Cre. These features, together with utility as highly specific Gal4 drivers, make gene trap mutants presented here especially useful to the research community.

Indexed as

DNA Transposable ElementsAnimalsAnimals, Genetically ModifiedGenes, ReporterGenetic VectorsGreen Fluorescent ProteinsMutagenesis, InsertionalZebrafishZebrafish ProteinsDNA Transposable ElementsGreen Fluorescent ProteinsZebrafish Proteins

Identifiers

PMID24034702
PMCPMC3848861
OpenAlexW2066336965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.